Literature DB >> 956651

In vitro induction of F1 hybrid anti-parent cell-mediated cytotoxicity.

G M Shearer, C A Garbarino, G Cudkowicz.   

Abstract

Spleen cells from normal (C57BL/6 X DBA/2)F1 mice were sensitized in vitro for 5 days with irradiated C57BL/6 or DBA/2 parental stimulating cells. Effector cells were generated which specifically lysed 51Cr-labeled targets (leukemia or mitogen-stimulated lymphoid cells) H-2-matched with the parental genotype used for sensitization. The response of F1 spleen cells to the C57BL/6 parent was stronger and more reproducible than that to the DBA/2 parent. The kinetics of generation of effector cells were similar for the F1 anti-parent and an F1 anti-allogeneic response. However, the magnitude of the F1 anti-C57BL/6 cytotoxic response was considerably lower than the F1 response to allogeneic cells. The ratio of responder to stimulator cells in the cultures was more critical for the former than for the latter response. Several lots of fetal bovine serum were found to be adequate for supplementing the medium in the induction of J1 hybrid anti-parent and anti-allogeneic cytotoxic effector cells. Based on these and other studies, it would appear that the F1 hybrid anti-parent cytotoxic response provides an in vitro model of murine hemopoietic graft rejection in vivo. This response may be elicited by a mechanism distinct from T cell-mediated cytotoxicity and involve different subpopulations of spleen cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 956651

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Presence of host-reactive T cells in lymphohaematopoietic chimeras.

Authors:  J D Waterfield; I D King; R W Dutton
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

2.  Cell-mediated cytotoxicity against targets bearing Sendai virus glycoproteins in the absence of viral infection.

Authors:  T F Abidi; T D Flanagan
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

Review 3.  Tolerance, the thymus, and suppressor T cells.

Authors:  B H Waksman
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

4.  A genetic analysis of natural resistance to nonsyngeneic cells: the role of H-2.

Authors:  G A Carlson; B A Taylor; S T Marshall; A H Greenberg
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

5.  Requirement of H-2-subregion differences for graft-versus-host autoimmunity in mice: superiority of the differences at class-II H-2 antigens (I-A/I-E).

Authors:  M Kimura; F M van Rappard-van der Veen; E Gleichmann
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

6.  H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. II. H-2D region control of H-7.1-specific stimulator function in mixed lymphocyte culture and susceptibility to lysis by H-7.1-specific cytotoxic cells.

Authors:  P J Wettstein; J A Frelinger
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

7.  Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro.

Authors:  T M Dexter; M A Moore; A P Sheridan
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

8.  Growth of SJL/J-derived transplantable reticulum cell sarcoma as related to its ability to induce T-cell proliferation in the host. I. Dominant negative genetic influences of other parent haplotype in F1 hybrids of SJL/J mice.

Authors:  I R Katz; S P Lerman; N M Ponzio; D C Shreffler; G J Thorbecke
Journal:  J Exp Med       Date:  1980-02-01       Impact factor: 14.307

9.  Differentiation from precursors in athymic nude mouse bone marrow of unusual spontaneously cytolytic cells showing anti-self-H-2 specificity and bearing T cell markers.

Authors:  J Reimann; R G Miller
Journal:  J Exp Med       Date:  1983-11-01       Impact factor: 14.307

10.  Exclusive involvement of H-2Db or H-2Kd product in the interaction between T-killer lymphocytes and syngeneic H-2b or H-2d viral lymphomas.

Authors:  E Gomard; V Duprez; T Reme; M J Colombani; J P Levy
Journal:  J Exp Med       Date:  1977-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.